1. Home
  2. COCP vs RBOT Comparison

COCP vs RBOT Comparison

Compare COCP & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.05

Market Cap

15.3M

Sector

Health Care

ML Signal

N/A

Logo Vicarious Surgical Inc.

RBOT

Vicarious Surgical Inc.

N/A

Current Price

$2.48

Market Cap

17.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
RBOT
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3M
17.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
COCP
RBOT
Price
$1.05
$2.48
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$6.00
$7.00
AVG Volume (30 Days)
103.2K
186.0K
Earning Date
11-14-2025
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$1.81
52 Week High
$2.67
$16.35

Technical Indicators

Market Signals
Indicator
COCP
RBOT
Relative Strength Index (RSI) 48.85 47.10
Support Level $1.03 $2.40
Resistance Level $1.19 $2.75
Average True Range (ATR) 0.06 0.30
MACD -0.01 0.03
Stochastic Oscillator 22.73 13.98

Price Performance

Historical Comparison
COCP
RBOT

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.

Share on Social Networks: